Back to 
Driehaus Capital Management LLC
Driehaus Capital Management LLC
AR2
3 quarters
Position history for Driehaus Capital Management LLC's holdings in ARRAY BIOPHARMA INC
As of its Q2 2019 13F, Driehaus Capital Management held 432,003 shares of AR2 (Array Biopharma), worth $20M. Driehaus Capital Management's 13F filings listed AR2 from Q1 2019 to Q2 2019, 2 quarterly filings. AR2 was 0.6% of Driehaus Capital Management's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$44.1M
Total Shares Change
-1.8M
Quarter-by-Quarter History
Other major holders of AR2: Farallon Capital Management, L.L.C., Citadel Advisors LLC, HBK Investments L.P., Magnetar Financial LLC, Millennium Management LLC